Animal study · rats
MOTS-c eased lung ischemia-reperfusion injury and deaths in rats
Checked against the paper Animal studyPublished by PepVault
The takeaway
This adds rat evidence that MOTS-c can lessen lung damage when blood flow returns after being cut off, plus early patient data using it only as a warning marker after bypass surgery, not as a treatment.
- Kind
- Animal study
- Studied in
- Rats
- Published
- 2025
- Journal
- Redox Biol
What they tested
The team asked whether MOTS-c protects the lung from ischemia-reperfusion injury, damage when blood flow is cut off and then restored, and whether blood MOTS-c levels can predict lung failure after heart-lung bypass surgery.
How the study was done
A preclinical study in rat models of lung ischemia-reperfusion injury, with lab work on cells exposed to low oxygen and then oxygen again. It also measured blood MOTS-c in patients during the first 24 h after cardiopulmonary bypass (a heart-lung machine used in surgery).

What they found
In rats, MOTS-c given as a treatment reduced lung injury, oxidative damage (harm from reactive oxygen molecules), inflammation and deaths. In the rat models, endothelial cells, the cells lining blood vessels, raised their own MOTS-c the most, and this tracked with a better-kept lung barrier and less oxidative stress. In patients, the rise in blood MOTS-c within 24 h after bypass predicted ARDS (acute respiratory distress syndrome, a severe form of lung failure) better than standard markers. Prediction models that included this rise reached an AUC of 0.885, where AUC scores how well a test separates people who get ARDS from those who don't.
What it doesn’t show
MOTS-c was tested as a treatment only in rats, so the protective effect is not a human result. The patient part only used MOTS-c as a blood marker to predict risk, and the 0.885 score came from models that combined it with other factors.
The paper
Li et al. MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes. Redox Biol. 2025.
The compound
More studies on MOTS-c
- MOTS-c rose after 16 weeks of exercise in non-Hispanic White survivorsRandomized trial · people · 2021
- MOTS-c reduced islet cell senescence and glucose intolerance in miceAnimal study · mice · 2025
- MOTS-c improved heart mitochondrial respiration in diabetic ratsAnimal study · rats · 2025
- MOTS-c prevented muscle atrophy, raised muscle glucose uptake in miceAnimal study · mice · 2024
- MOTS-c raised testosterone, LH and FSH in obese and non-obese ratsAnimal study · rats · 2024
- MOTS-c improved heart small-vessel barrier under endotoxin in miceAnimal study · mice · 2024
- Every study on MOTS-c
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.